title: Infliximab induced liver injury in Crohn's disease: a challenging diagnosis.
authors.affiliation: Gastroenterology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal. Electronic address: joanameloc@gmail.com.
authors.forename: Joana
authors.initials: J
authors.lastname: Carvalheiro
authors.affiliation: Gastroenterology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
authors.forename: Sofia
authors.initials: S
authors.lastname: Mendes
authors.affiliation: Gastroenterology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
authors.forename: Carlos
authors.initials: C
authors.lastname: Sofia
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D056487:Chemical and Drug Induced Liver Injury, Chronic / Q000175:diagnosis* / Q000209:etiology*; D002779:Cholestasis / Q000209:etiology; D003424:Crohn Disease / Q000188:drug therapy; D003937:Diagnosis, Differential; D005765:Gastrointestinal Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006521:Hepatitis, Chronic / Q000209:etiology; D006801:Humans; D000069285:Infliximab; D008111:Liver Function Tests; D008297:Male
chemical_list: D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D000069285:Infliximab